Marsh & Mclennan Companies, Inc. (MRSH) Stock Analysis and Metrics

Marsh & Mclennan Companies

NYSE: MRSH

$180.68 ▲ +4.29 (+2.43%)

At close: Jul 24, 2026 · 3:59 PM UTC

Financial Ratios

Market Cap84.27 Bn

P/E20.80

P/S3.02

Div. Yield0.03

ROIC (Qtr)0.01

Total Debt (Qtr)20.56 Bn

Revenue Growth (1y) (Qtr)6.17

Add ratio to table…

About

Marsh & McLennan Companies, Inc. is a global professional services firm that delivers risk and insurance solutions, reinsurance broking, health wealth and career advice, and management consulting to clients in approximately 130 countries. The firm reported annual revenue of twenty seven billion dollars and employed more than ninety five thousand colleagues worldwide as of the end of 2025. Effective January 14 2026 the company updated its brand name from Marsh McLennan to Marsh and renamed its Marsh and Oliver Wyman Group businesses to Marsh Risk and Marsh Management Consulting respectively, while Mercer and Guy Carpenter retain their current brands during a transition period. Marsh & McLennan Companies, Inc. helps organizations manage uncertainty, optimize talent and investments, and improve overall performance through integrated advisory and brokerage services that combine risk expertise with human capital insights.

Marsh & McLennan Companies, Inc. generates revenue mainly through commissions and fees for insurance and reinsurance brokerage, risk advisory, and consulting services. In the Risk and Insurance Services segment, income is derived from brokerage commissions paid by insurers and reinsurers, consulting fees for risk management and alternative risk financing, and interest earned on fiduciary funds such as premiums and claims proceeds held for clients. The segment also receives contingent commissions tied to the volume or profitability of placements, and fees for administrative services including underwriting and quota share management. In the Consulting segment, revenue comes from client fees for health wealth and career advice, asset based charges for investment management and retirement plan services, and commissions linked to the placement of insurance contracts and retirement products. Additionally, certain consulting activities generate sub advisor fees reported on a gross basis and fees for actuarial and economic analysis services.

The company operates through the following segments: Risk and Insurance Services and Consulting.

• Risk and Insurance Services comprises Marsh Risk and Guy Carpenter and provides a broad suite of services including insurance broking, risk management, alternative risk financing, reinsurance broking, strategic advisory, actuarial services, analytics, and insurance linked securities solutions to businesses, government entities, professional service organizations and individuals across the globe. Marsh Risk operates through units such as Corporate which serves middle market clients globally through Marsh McLennan Agency, Commercial & Consumer which handles less complex risks through Victor Insurance Managers, Affinity and personal lines businesses, and specialist advisory units offering risk consulting, captive solutions and international placement services. Guy Carpenter functions as a reinsurance intermediary and advisor delivering treaty and facultative reinsurance broking, strategic advisory, actuarial services, analytics, and capital markets solutions through its divisions GC Securities which structures and places insurance linked securities such as catastrophe bonds and sidecar vehicles, and GC Capital & Advisory which provides corporate finance advice including mergers and acquisitions guidance and capital raising. This segment generated about sixty four percent of the company's total revenue in 2025 and employed approximately fifty five thousand seven hundred colleagues, with Marsh Risk contributing roughly fifty four percent of revenue and Guy Carpenter contributing about ten percent.

• Consulting consists of Mercer and Marsh Management Consulting and delivers health wealth and career advice, investment consulting, brand strategy, economic analysis and management consulting services to a wide range of clients. Mercer operates in three main practice areas: Health which assists employers with employee health programs compliance and benefits outsourcing, Wealth which provides actuarial investment consulting and investment management services managing approximately six hundred ninety two billion dollars in assets worldwide at the end of 2025, and Career which advises on employee engagement skill assessment executive remuneration HR effectiveness and M&A strategy using proprietary data and tools. Marsh Management Consulting offers advisory services through its operating units Oliver Wyman which includes specializations such as Actuarial AI Transformation Climate and Sustainability Customer Innovation and Growth Finance Risk and Restructuring Mergers and Acquisitions and Performance Transformation, Lippincott which focuses on brand strategy and design, and NERA Economic Consulting which provides economic analysis for complex business and legal issues. This segment generated about thirty six percent of the company's total revenue in 2025 and employed approximately twenty nine thousand one hundred colleagues, with Mercer contributing roughly twenty three percent of revenue and Marsh Management Consulting contributing about thirteen percent.

Marsh & McLennan Companies, Inc. holds a leading position in the global risk and insurance brokerage and consulting markets, ranking among the largest firms by revenue and employee count. The company faces competition from other international brokerage houses, independent insurers, commercial and investment banks, consulting firms and digital platforms that offer similar services. Despite this competitive environment, Marsh & McLennan differentiates itself through its integrated approach that combines risk expertise with human capital solutions, its extensive global network covering more than 130 countries, its deep bench of actuarial analytics and data science capabilities, and its strong reputation built on long standing client relationships. The firm also benefits from scale advantages in talent acquisition, technology investment, and access to diverse capital markets, which help it maintain pricing power and sustain growth across its business lines.

The company serves a diverse customer base that includes large corporations, mid market enterprises, government agencies, professional service organizations, insurance carriers, employers seeking health and retirement solutions, high net worth individuals and family offices, and individuals needing personal insurance and wealth management services. Marsh Risk and Guy Carpenter work with businesses of all sizes to design insurance programs, manage risk exposures and access reinsurance markets, while Mercer and Marsh Management Consulting advise organizations on employee benefits, investment strategies and organizational performance. This broad mix of clients allows the firm to generate revenue from multiple sources and to cross sell complementary risk and consulting solutions across its global footprint.

Investment Thesis

▲ Bull case

Marsh & McLennan Companies is positioned to capitalize on its AI-driven transformation beyond current margin guidance, with the company strategically embedding artificial intelligence across its core value chain to create defensible competitive advantages that are not fully reflected in near-term financial metrics. Management emphasized AI as a three-pillar strategy focused on growth, productivity, and efficiency, citing specific tools like Claims IQ, Marsh Risk Cortex, and GC Quotebox that are already generating measurable outcomes—such as a 50% increase in sales velocity in pilot programs for coverage gap analysis and quote comparison—yet these benefits are not yet fully priced into the stock given the market's focus on cyclical headwinds in reinsurance pricing and fiduciary interest income. The company's scale allows it to invest heavily in AI infrastructure while leveraging proprietary data assets from 155 years of client relationships, creating a moat that pure-play tech firms cannot replicate, especially as Oliver Wyman's AI Quotient team—identified as its fastest-growing practice—has already advised on over $50 billion in AI-related capital investments, signaling a structural shift toward higher-margin, technology-enabled advisory services that will compound over time. This AI edge is further reinforced by recent leadership appointments at Oliver Wyman, including a new Chief AI and Data Officer and Head of Strategy and Growth, which signal a deliberate organizational pivot to scale AI capabilities across consulting, risk, and investment businesses, positioning Marsh to capture value not just from internal efficiency but from new revenue streams in AI strategy implementation, workforce transformation, and data-driven decision-making for clients navigating technological disruption.
The pending AltamarCAM acquisition represents a transformative, underappreciated catalyst that could significantly reshape Marsh's growth trajectory and financial profile beyond the current quarter's results, with the deal adding approximately $20 billion in assets under management to Mercer's platform and substantially expanding its capabilities in private markets—a high-growth, less cyclical segment where management has explicitly identified strategic priority. While management acknowledged the transaction is subject to regulatory approval and expects closure later in the year, they highlighted its strategic fit in expanding Mercer's private markets platform through expertise in secondaries, co-investments, bespoke accounts, and evergreen vehicles, which directly addresses growing client demand for sophisticated multi-asset solutions in an environment where traditional pension plans are shifting toward defined contribution models and alternative investments. This acquisition would not only boost Mercer's already strong AUM growth—up 19% year-over-year to $727 billion—but also diversify revenue streams away from fee compression risks in traditional consulting and insurance brokerage, leveraging Marsh's position as the world's largest OCIO to cross-sell integrated risk and investment solutions to institutional clients globally, a synergy that remains underdiscussed in current market sentiment focused on near-term pricing pressures. The deal exemplifies Marsh's disciplined 'string of pearls' M&A strategy, where high-quality, bolt-on acquisitions like TriBridge Partners (recently closed in MMA) and CR3 Partners (for Oliver Wyman's restructuring capabilities) are quietly building incremental growth engines that compound over time, yet the market appears to be overlooking the cumulative impact of these transactions on long-term organic growth potential.
Marsh's Thrive efficiency program is on track to deliver $400 million in total savings by year-end, with approximately $500 million in associated charges, creating a powerful reinvestment engine that will fund future growth initiatives in producer talent, AI development, and high-potential organic opportunities—yet the market is underestimating how these savings will translate into sustained margin expansion and earnings resilience amid persistent insurance rate declines. Management explicitly linked Thrive savings to growth investments, noting that the program is designed not just to cut costs but to strengthen the brand and generate efficiency gains that will be redeployed into areas with the highest return, such as AI-enabled tools and middle-market expansion through MMA, where pricing has historically been more stable through cycles and the company sees significant upside from relatively modest current penetration. This creates a virtuous cycle where operational efficiency fuels top-line growth without diluting margins, contrasting with peers who may be forced to choose between cost-cutting and growth investment, and it supports Marsh's guidance for continued margin expansion through 2026 despite headwinds from lower interest rates and declining P&C rates, a feat achieved for 18 consecutive years and expected to reach 19 in the current year. The program's progress—already generating $37 million in savings-related costs in Q1—demonstrates disciplined execution, and its scale relative to the company's $7.6 billion quarterly revenue suggests that even incremental improvements in efficiency compound meaningfully over time, especially as AI automation in the Business and Client Services unit continues to scale, with document ingestion now handling thousands of documents weekly and improving efficiency by 20%, a metric that is likely to improve further as more workflows are digitized.

Marsh & McLennan Companies is positioned to capitalize on its AI-driven transformation beyond current margin guidance, with the company strategically embedding artificial intelligence across its core value chain to create defensible competitive advantages that are not fully reflected in near-term financial metrics. Management emphasized AI as a three-pillar strategy focused on growth, productivity, and efficiency, citing specific tools like Claims IQ, Marsh Risk Cortex, and GC Quotebox that are already generating measurable outcomes—such as a 50% increase in sales velocity in pilot programs for coverage gap analysis and quote comparison—yet these benefits are not yet fully priced into the stock given the market's focus on cyclical headwinds in reinsurance pricing and fiduciary interest income. The company's scale allows it to invest heavily in AI infrastructure while leveraging proprietary data assets from 155 years of client relationships, creating a moat that pure-play tech firms cannot replicate, especially as Oliver Wyman's AI Quotient team—identified as its fastest-growing practice—has already advised on over $50 billion in AI-related capital investments, signaling a structural shift toward higher-margin, technology-enabled advisory services that will compound over time. This AI edge is further reinforced by recent leadership appointments at Oliver Wyman, including a new Chief AI and Data Officer and Head of Strategy and Growth, which signal a deliberate organizational pivot to scale AI capabilities across consulting, risk, and investment businesses, positioning Marsh to capture value not just from internal efficiency but from new revenue streams in AI strategy implementation, workforce transformation, and data-driven decision-making for clients navigating technological disruption.
The pending AltamarCAM acquisition represents a transformative, underappreciated catalyst that could significantly reshape Marsh's growth trajectory and financial profile beyond the current quarter's results, with the deal adding approximately $20 billion in assets under management to Mercer's platform and substantially expanding its capabilities in private markets—a high-growth, less cyclical segment where management has explicitly identified strategic priority. While management acknowledged the transaction is subject to regulatory approval and expects closure later in the year, they highlighted its strategic fit in expanding Mercer's private markets platform through expertise in secondaries, co-investments, bespoke accounts, and evergreen vehicles, which directly addresses growing client demand for sophisticated multi-asset solutions in an environment where traditional pension plans are shifting toward defined contribution models and alternative investments. This acquisition would not only boost Mercer's already strong AUM growth—up 19% year-over-year to $727 billion—but also diversify revenue streams away from fee compression risks in traditional consulting and insurance brokerage, leveraging Marsh's position as the world's largest OCIO to cross-sell integrated risk and investment solutions to institutional clients globally, a synergy that remains underdiscussed in current market sentiment focused on near-term pricing pressures. The deal exemplifies Marsh's disciplined 'string of pearls' M&A strategy, where high-quality, bolt-on acquisitions like TriBridge Partners (recently closed in MMA) and CR3 Partners (for Oliver Wyman's restructuring capabilities) are quietly building incremental growth engines that compound over time, yet the market appears to be overlooking the cumulative impact of these transactions on long-term organic growth potential.
Marsh's Thrive efficiency program is on track to deliver $400 million in total savings by year-end, with approximately $500 million in associated charges, creating a powerful reinvestment engine that will fund future growth initiatives in producer talent, AI development, and high-potential organic opportunities—yet the market is underestimating how these savings will translate into sustained margin expansion and earnings resilience amid persistent insurance rate declines. Management explicitly linked Thrive savings to growth investments, noting that the program is designed not just to cut costs but to strengthen the brand and generate efficiency gains that will be redeployed into areas with the highest return, such as AI-enabled tools and middle-market expansion through MMA, where pricing has historically been more stable through cycles and the company sees significant upside from relatively modest current penetration. This creates a virtuous cycle where operational efficiency fuels top-line growth without diluting margins, contrasting with peers who may be forced to choose between cost-cutting and growth investment, and it supports Marsh's guidance for continued margin expansion through 2026 despite headwinds from lower interest rates and declining P&C rates, a feat achieved for 18 consecutive years and expected to reach 19 in the current year. The program's progress—already generating $37 million in savings-related costs in Q1—demonstrates disciplined execution, and its scale relative to the company's $7.6 billion quarterly revenue suggests that even incremental improvements in efficiency compound meaningfully over time, especially as AI automation in the Business and Client Services unit continues to scale, with document ingestion now handling thousands of documents weekly and improving efficiency by 20%, a metric that is likely to improve further as more workflows are digitized.

▼ Bear case

Marsh & McLennan Companies faces significant near-term headwinds from persistent downward pressure in commercial insurance and reinsurance pricing, which management acknowledged is directly impacting top-line growth and may persist beyond current expectations, with the Marsh Global Insurance Market Index showing a 5% decline in primary commercial insurance rates in Q1 FY26—driven largely by a 9% drop in property rates and 5% declines in financial/professional liability and cyber lines—creating a structural challenge for the Risk & Insurance Services segment that offset underlying growth of only 3% despite solid new business generation. While management highlighted strong new business and client retention, they conceded that the pricing environment remains challenging, particularly for Guy Carpenter, which grew just 2% on an underlying basis due to a 'very soft property cat reinsurance market' and explicitly stated it is 'not likely to be Guy Carpenter's best growth year this year,' suggesting the segment's performance may remain subdued through at least mid-2026 as traditional reinsurance cycles reset, with no clear indication of when rate declines will stabilize or reverse, especially given the continued influx of third-party capital ($2 billion in new inflows cited in the quarter) and strong reinsurer profitability sustaining ample capacity. This pricing pressure is not merely cyclical but reflects a broader market dynamic where capital abundance and competition are suppressing rates across key lines, directly constraining revenue growth in the company's largest segment (Risk & Insurance Services at $5.1 billion in revenue) and potentially limiting the ability to offset declining fiduciary interest income—which fell $18 million year-over-year and is guided to approximately $80 million in Q2—through top-line expansion, forcing greater reliance on expense management and share buybacks to drive EPS growth.
The $425 million litigation charge related to the Greensill collapse represents a material, non-recurring drag on GAAP profitability that management downplayed during the earnings call despite its significant impact on operating income, which decreased 19% in Risk & Insurance Services and 12% consolidated when including the charge, yet they framed it as a 'best estimate' tied to court-sponsored mediation without addressing potential for further escalation or additional reserves should litigation outcomes prove unfavorable, creating an unquantified risk that could resurface in future quarters if settlements or judgments exceed current accruals. While the company disclosed the charge in its 10-Q and noted the litigation is ongoing, they declined to comment further during Q&A, leaving investors without clarity on whether this is a final resolution or the beginning of a prolonged legal process with potential for additional financial impact, especially given the historical complexity of Greenfield Capital-related cases and the involvement of multiple counterparties across structured finance and insurance markets. This lack of transparency around a sizable and uncertain liability contrasts with the company's usual emphasis on predictability and could undermine confidence in earnings quality if similar charges emerge from other legacy exposures, particularly as the benefit of the charge's exclusion from adjusted metrics may lead investors to overlook its real economic cost to the business, especially when considering that adjusted operating income growth of 8% was achieved only by backing out this significant item, masking underlying volatility in core operations.
Marsh's capital allocation strategy, while disciplined in principle, carries execution risk in the current environment where M&A valuations may not have adjusted sufficiently to reflect broader market sentiment, potentially leading to overpayment for acquisitions like AltamarCAM or reduced effectiveness of share repurchases if the stock remains undervalued for extended periods, a concern raised by analysts during Q&A who noted that 'the public brokers, the stock prices, everyone's reset lower' yet questioned whether M&A pricing has similarly reset, suggesting a disconnect between public market valuations and private transaction prices that could result in suboptimal returns on deployed capital. Management affirmed their bias toward reinvestment and growth via M&A but acknowledged growing gaps between bid and ask prices and increased aggression from financial sponsors versus strategics, which could complicate deal execution and extend timelines for the AltamarCAM closure, thereby delaying expected synergies and AUM growth contributions while still consuming management attention and resources—especially problematic given the company's goal to deploy approximately $5 billion in capital during 2026 across dividends, acquisitions, and repurchases, a target that may prove difficult to meet if M&A pipelines remain light and buybacks are increased as a default, potentially signaling a lack of attractive internal investment opportunities despite strong cash generation. Furthermore, the reliance on share repurchases as a flexible tool when M&A is light—while fiscally prudent—may not address long-term growth needs if organic opportunities are constrained by market conditions, and the company's guidance for underlying revenue growth similar to 2025 levels (which was 4% underlying) implies limited acceleration potential, raising questions about whether the current capital deployment plan can sustain historical growth rates without meaningful innovation or market tailwinds.

Marsh & McLennan Companies faces significant near-term headwinds from persistent downward pressure in commercial insurance and reinsurance pricing, which management acknowledged is directly impacting top-line growth and may persist beyond current expectations, with the Marsh Global Insurance Market Index showing a 5% decline in primary commercial insurance rates in Q1 FY26—driven largely by a 9% drop in property rates and 5% declines in financial/professional liability and cyber lines—creating a structural challenge for the Risk & Insurance Services segment that offset underlying growth of only 3% despite solid new business generation. While management highlighted strong new business and client retention, they conceded that the pricing environment remains challenging, particularly for Guy Carpenter, which grew just 2% on an underlying basis due to a 'very soft property cat reinsurance market' and explicitly stated it is 'not likely to be Guy Carpenter's best growth year this year,' suggesting the segment's performance may remain subdued through at least mid-2026 as traditional reinsurance cycles reset, with no clear indication of when rate declines will stabilize or reverse, especially given the continued influx of third-party capital ($2 billion in new inflows cited in the quarter) and strong reinsurer profitability sustaining ample capacity. This pricing pressure is not merely cyclical but reflects a broader market dynamic where capital abundance and competition are suppressing rates across key lines, directly constraining revenue growth in the company's largest segment (Risk & Insurance Services at $5.1 billion in revenue) and potentially limiting the ability to offset declining fiduciary interest income—which fell $18 million year-over-year and is guided to approximately $80 million in Q2—through top-line expansion, forcing greater reliance on expense management and share buybacks to drive EPS growth.
The $425 million litigation charge related to the Greensill collapse represents a material, non-recurring drag on GAAP profitability that management downplayed during the earnings call despite its significant impact on operating income, which decreased 19% in Risk & Insurance Services and 12% consolidated when including the charge, yet they framed it as a 'best estimate' tied to court-sponsored mediation without addressing potential for further escalation or additional reserves should litigation outcomes prove unfavorable, creating an unquantified risk that could resurface in future quarters if settlements or judgments exceed current accruals. While the company disclosed the charge in its 10-Q and noted the litigation is ongoing, they declined to comment further during Q&A, leaving investors without clarity on whether this is a final resolution or the beginning of a prolonged legal process with potential for additional financial impact, especially given the historical complexity of Greenfield Capital-related cases and the involvement of multiple counterparties across structured finance and insurance markets. This lack of transparency around a sizable and uncertain liability contrasts with the company's usual emphasis on predictability and could undermine confidence in earnings quality if similar charges emerge from other legacy exposures, particularly as the benefit of the charge's exclusion from adjusted metrics may lead investors to overlook its real economic cost to the business, especially when considering that adjusted operating income growth of 8% was achieved only by backing out this significant item, masking underlying volatility in core operations.
Marsh's capital allocation strategy, while disciplined in principle, carries execution risk in the current environment where M&A valuations may not have adjusted sufficiently to reflect broader market sentiment, potentially leading to overpayment for acquisitions like AltamarCAM or reduced effectiveness of share repurchases if the stock remains undervalued for extended periods, a concern raised by analysts during Q&A who noted that 'the public brokers, the stock prices, everyone's reset lower' yet questioned whether M&A pricing has similarly reset, suggesting a disconnect between public market valuations and private transaction prices that could result in suboptimal returns on deployed capital. Management affirmed their bias toward reinvestment and growth via M&A but acknowledged growing gaps between bid and ask prices and increased aggression from financial sponsors versus strategics, which could complicate deal execution and extend timelines for the AltamarCAM closure, thereby delaying expected synergies and AUM growth contributions while still consuming management attention and resources—especially problematic given the company's goal to deploy approximately $5 billion in capital during 2026 across dividends, acquisitions, and repurchases, a target that may prove difficult to meet if M&A pipelines remain light and buybacks are increased as a default, potentially signaling a lack of attractive internal investment opportunities despite strong cash generation. Furthermore, the reliance on share repurchases as a flexible tool when M&A is light—while fiscally prudent—may not address long-term growth needs if organic opportunities are constrained by market conditions, and the company's guidance for underlying revenue growth similar to 2025 levels (which was 4% underlying) implies limited acceleration potential, raising questions about whether the current capital deployment plan can sustain historical growth rates without meaningful innovation or market tailwinds.

Segments Breakdown of Revenue (2025)

Peer Comparison

Companies in the Insurance Brokers

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	MRSH	Marsh & Mclennan Companies, Inc.	84.27 Bn	20.80	3.02	20.56 Bn
2	AON	Aon plc	75.99 Bn	19.03	4.35	14.66 Bn
3	AJG	Arthur J. Gallagher & Co.	62.23 Bn	38.51	4.17	12.72 Bn
4	WTW	Willis Towers Watson Plc	27.24 Bn	16.09	2.74	6.30 Bn
5	BRO	Brown & Brown, Inc.	23.60 Bn	15.12	3.69	7.89 Bn
6	NP	Neptune Insurance Holdings Inc.	4.12 Bn	-170.66	26.55	0.23 Bn
7	ARX	Accelerant Holdings	3.06 Bn	-2.15	30.17	0.12 Bn
8	CRVL	Corvel Corp	3.03 Bn	28.64	3.22	-

Research Tools

Developers

About

Investment Thesis

Geographical Breakdown of Revenue (2025)

Segments Breakdown of Revenue (2025)

Peer Comparison

Research Tools

Developers

About

Investment Thesis

Geographical Breakdown of Revenue (2025)

Segments Breakdown of Revenue (2025)

Peer Comparison

Create an account

Sign In

Reset Password